Product Name
ACTL7A, Polyclonal Antibody
Full Product Name
ACTL7A, NT (ACTL7A, Actin-like protein 7A, Actin-like-7-alpha)
Product Synonym Names
Anti -ACTL7A, NT (ACTL7A, Actin-like protein 7A, Actin-like-7-alpha)
Product Gene Name
anti-ACTL7A antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 9; NC_000009.11 (111624603..111626035). Location: 9q31
3D Structure
ModBase 3D Structure for Q9Y615
Purity/Purification
Affinity Purified
Purified by Protein A affinity chromatography.
Form/Format
Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.
Immunogen
ACTL7A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 48-75 amino acids from the N-terminal region of human ACTL7A.
Preparation and Storage
May be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Other Notes
Small volumes of anti-ACTL7A antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-ACTL7A antibody
ACTL7A is a member of a family of actin-related proteins (ARPs) which share significant amino acid sequence identity to conventional actins. Both actins and ARPs have an actin fold, which is an ATP-binding cleft, as a common feature. The ARPs are involved in diverse cellular processes, including vesicular transport, spindle orientation, nuclear migration and chromatin remodeling. ACTL7A (ACTL7A), and related gene, ACTL7B, are intronless, and are located approximately 4 kb apart in a head-to-head orientation within the familial dysautonomia candidate region on 9q31. Based on mutational analysis of the ACTL7A gene in patients with this disorder, it was concluded that it is unlikely to be involved in the pathogenesis of dysautonomia. The ACTL7A gene is expressed in a wide variety of ***** tissues, however, its exact function is not known.
Product Categories/Family for anti-ACTL7A antibody
Antibodies; Abs to Actin Related Proteins
Applications Tested/Suitable for anti-ACTL7A antibody
ELISA (EL/EIA), Western Blot (WB)
Application Notes for anti-ACTL7A antibody
Suitable for use in Western Blot, ELISA
Dilution: ELISA: 1:1,000
Western Blot: 1:100-500
NCBI/Uniprot data below describe general gene information for ACTL7A. It may not necessarily be applicable to this product.
NCBI Accession #
NP_006678.1
[Other Products]
NCBI GenBank Nucleotide #
NM_006687.3
[Other Products]
UniProt Primary Accession #
Q9Y615
[Other Products]
UniProt Secondary Accession #
Q5JSV0; B2RC83[Other Products]
UniProt Related Accession #
Q9Y615[Other Products]
Molecular Weight
48,644 Da[Similar Products]
NCBI Official Full Name
actin-like protein 7A
NCBI Official Synonym Full Names
actin-like 7A
NCBI Official Symbol
ACTL7A??[Similar Products]
NCBI Protein Information
actin-like protein 7A; actin-like 7-alpha; actin-like-7-alpha
UniProt Protein Name
Actin-like protein 7A
UniProt Synonym Protein Names
Actin-like-7-alpha
Protein Family
Actin-like protein
UniProt Gene Name
ACTL7A??[Similar Products]
UniProt Entry Name
ACL7A_HUMAN
NCBI Summary for ACTL7A
The protein encoded by this gene is a member of a family of actin-related proteins (ARPs) which share significant amino acid sequence identity to conventional actins. Both actins and ARPs have an actin fold, which is an ATP-binding cleft, as a common feature. The ARPs are involved in diverse cellular processes, including vesicular transport, spindle orientation, nuclear migration and chromatin remodeling. This gene (ACTL7A), and related gene, ACTL7B, are intronless, and are located approximately 4 kb apart in a head-to-head orientation within the familial dysautonomia candidate region on 9q31. Based on mutational analysis of the ACTL7A gene in patients with this disorder, it was concluded that it is unlikely to be involved in the pathogenesis of dysautonomia. The ACTL7A gene is expressed in a wide variety of ***** tissues, however, its exact function is not known. [provided by RefSeq, Jul 2008]
UniProt Comments for ACTL7A
Subunit structure: Interacts (via N-terminus) with TES (via LIM domain 2). Heterodimer with TES; the heterodimer interacts with ENAH to form a heterotrimer. Ref.7
Subcellular location: Cytoplasm ? cytoskeleton
By similarity. Golgi apparatus
By similarity. Cytoplasm
By similarity. Nucleus
By similarity. Note: Detected at the Golgi apparatus during acrosome biogenesis. Detected at the subacrosomal layer in round spermatids. Detected in sperm head and tail
By similarity.
Tissue specificity: Strongly expressed in testis. Also expressed in other tissues. Ref.1
Sequence similarities: Belongs to the actin family.
Research Articles on ACTL7A
1. Anti-ACTL7a antibodies may cause infertility in mice because the in vitro treatment of mouse spermatozoa with ACTL7a antibody-containing serum markedly reduced the fertilizing potential of the spermatozoa.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.